[1] Petrof, B., Shrager, J., Stedman, H., Kelley, A. and Sweeney, H. (1993) Dystrophin Protects the Sarcolemma from Stresses Developed during Muscle Contraction. Proceedings of the National Academy of Sciences of the United States of America, 90, 3710-3714.
http://www.pnas.org/content/90/8/3710.full.pdf
[2] Emery, A.E. (2002) The Muscular Dystrophies. The Lancet, 359, 687-695.
http://dx.doi.org/10.1016/S0140-6736(02)07815-7
[3] Bach, R.J. (1999) Introduction In Guide to the Evaluation and Management of Neuro Muscular Disease. Hanley & Belfus Inc., Philadelphia, 1-4.
[4] Meryon, E. (1852) On Grannular and Fatty Degeneration of the Voluntary Muscles. Medico-Chirurgical Transactions, 35, 72-84.
[5] Duchenne, G.B.A. (1868) Researches Sur la paralysic musculaire pseudo hypertrophic or paralysie myo-sclero sique. Archives of General Psychiatry, 11, 5-25.
[6] Moser, H. (1984) Duchenne Muscular Dystrophy: Pathogenetic Aspects and Genetic Prevention. Human Genetics, 66, 17-40.
http://dx.doi.org/10.1007/BF00275183
[7] Emery, A.E. (1991) Population Frequencies of Inherited Neuro-muscular Disease—A World Survey. Neuromuscular Disorders, 1, 19-29.
http://dx.doi.org/10.1016/0960-8966(91)90039-U
[8] Abood, E.A. and Jones, M.M. (1991) Macrophages in Developing Mammalian Skeletal Muscle: Evidence for Muscle Fiber Death as a Normal Developmental Event. Acta Anatomica, 140, 201-212.
http://dx.doi.org/10.1159/000147059
[9] Simonds, A.K., Muntani, F., Heather, S. and Fielding, S. (1998) Impact of Nasal Ventilation on Survival in Hypercapnic Duchenne Muscular Dystrophy. Therax, 53, 949-952.
http://dx.doi.org/10.1136/thx.53.11.949
[10] Somer, H., Donner, M., Murros, J. and Konttinen, A. (1973) A Serum Isoenzyme Study in Muscular Dystrophy. Particular Reference to Creatine Kinase, Aspartate Aminotransferase, and Lactic Acid Dehydrogenase Isozymes. Archives of Neurology, 29, 343-345.
[11] Mokri, B. and Engel, A.G. (1975) Duchenne Dystrophy: Electron Microscopic Findings Pointing to a Basic or Early Abnormality in the Plasma Membrane of Muscle Fiber. Neurology, 25, 1111-1120.
http://dx.doi.org/10.1212/WNL.25.12.1111
[12] Engel, J., Furthmayr, H., Odermatt, E., von der Mark, H., Aumailley, M., Fleischmajer, R. and Timpl, R. (1985) Structure and Macromolecular Organization of Type VI Collagen. Annals of the New York Academy of Sciences, 460, 25-37.
[13] Gillis, J.M. (1999) Understanding Dystrophinopathies: An Inventory of the Structural and Functional Consequences of the Absence of Dystrophin in Muscles of the Mdx Mouse. Journal of Muscle Research & Cell Motility, 20, 605-625.
http://dx.doi.org/10.1023/A:1005545325254
[14] Sandri, M., Minetti, C., Pedemonte, M. and Carraro, U. (1998) Apoptotic Myonuclei in Human Duchenne Muscular Dystrophy. Laboratory Investigation, 78, 1005-1016.
[15] Tidball, J.G., Albrecht, D.E., Lokensgard, B.E. and Spencer, M.J. (1995) Apptasis Precedes Necrosis of Dystrophin-Deficient Muscle. Journal of Cell Science, 108, 2197-2204.
[16] Matsuda, R., Nishikawa, A. and Tanaka, H. (1995) Visualization of Dystrophic Muscle Fibers in Mdx Mouse by Vital Staining with Evans Blue: Evidence of Apoptosis in Dystrophin-Deficient Mouscle. The Journal of Biochemistry, 118, 959-963.
http://dx.doi.org/10.1093/jb/118.5.959
[17] Spencer, M.J., Walsh, C.M., Dorshkind, K.A., Rodriguez, E.M. and Tidball, J.G. (1997) Myonuclear Apoptosis in Dystrophic Mdx Muscles Occurs by Perforin-Mediated Cytotoxicity. Journal of Clinical Investigation, 99, 2745-2751.
http://dx.doi.org/10.1172/JCI119464
[18] Bradley, W.G., Hudgson, P., Larson, P.F., Papapetropoulas, T.A. and Jenkison, M. (1972) Structural Changes in the Early Stages of Duchenne Muscular Dystrophy. Journal of Neurology, Neurosurgery & Psychiatry, 35, 451-455.
http://dx.doi.org/10.1136/jnnp.35.4.451
[19] Bowman, W. (1840) On the Minute Structure and Movements of Voluntary Muscle. The Philosophical Transactions of the Royal Society, 130, 457-501.
[20] Murphy, D.L., Mendell, J.R. and Engel, W.K. (1973) Serotonin and Platelet Function in Duchenne’s Muscular Dystrophy. Archives of Neurology, 28, 239-242.
http://dx.doi.org/10.1001/archneur.1973.00490220047006
[21] Paulsan, O.F., Engel, A.G. and Gomez, M.R. (1974) Muscle Blood Flow in Duchenne Type Muscular Dystrophy, Limb-Gridle Dystrophy, Polymyositis and in Normal Controls. Journal of Neurology, Neurosurgery & Psychiatry, 37, 685-690.
http://dx.doi.org/10.1136/jnnp.37.6.685
[22] Jerusalem, F., Engel, A.G. and Gomez, M.R. (1974) Duchenne Dystrophy. I. Morphometric Study of the Muscle Microvascular. Brain, 97, 115-122.
http://dx.doi.org/10.1093/brain/97.1.115
[23] McComas, A.J., Sica, R.E.P. and Currie, S. (1971) An Electro-physiological Study of Duchenne Dystrophy. Journal of Neurology, Neurosurgery & Psychiatry, 34, 461-468.
http://dx.doi.org/10.1136/jnnp.34.4.461
[24] Panayiotopoulos, C.P., Scarpalezos, S. and Papapetropoulos, T. (1974) Electrophysiological Estimation of Motor Units in Duchenne Muscular Dystrophy. Journal of the Neurological Sciences, 23, 89-98.
http://dx.doi.org/10.1016/0022-510X(74)90145-2
[25] Ballantyne, J.P. and Hansen, S. (1974) New Method for Estimation of the Number of Motor Units in a Muscle. 2. Duchenne, Limb-Girdle and Facioscapulohumerol, and Myotonic Muscular Dystrophies. Journal of Neurology, Neurosurgery & Psychiatry, 37, 1195-1201.
http://dx.doi.org/10.1136/jnnp.37.11.1195
[26] Matheson, D.M. and Howland, J.L. (1974) Erythrocyte Deformation in Human Muscular Dystrophy. Science, 184, 165-166.
http://dx.doi.org/10.1126/science.184.4133.165
[27] Miale, T.D., Frias, J.L. and Lawson, D.L. (1975) Erythrocytes in Human Muscular Dystrophy. Science, 187, 453-454.
http://dx.doi.org/10.1126/science.1111115
[28] Miller, S.E., Roses, A.D. and Appel, S.H. (1975) Letter: Erythrocytes in Human Muscular Dystrophy. Science, 188, 1131.
http://dx.doi.org/10.1126/science.1215993
[29] Brown, H.D., Chattopadyay, S.K. and Patel, A.B. (1967) Erythrocyte Abnormality in Human Myopathy. Science, 157, 1577-1578.
http://dx.doi.org/10.1126/science.157.3796.1577
[30] Peter, J.B., Worsfold, M. and Pearson, C.M. (1969) Erythrocyte Ghost Adenosine Triphosphate (AT Pase) in Duchenne Dystrophy. Journal of Laboratory and Clinical Medicine, 74, 103-108.
[31] Roses, A.D., Herbstreith, M.H. and Appel, S.H. (1975) Membrane Protein Kinease Alteration in Duchenne Muscular Dystrophy. Nature, 254, 350-351.
http://dx.doi.org/10.1038/254350a0
[32] Mawatari, S., Takagi, A. and Rowland, L.P. (1974) Adenyl Cyclase in Normal and Pathologic Human Muscle. Archives of Neurology, 30, 96-102.
[33] Pearce, G.W., Pearce, J.M.S. and Walton, J.N. (1966) The Duchenne Type Muscular Dystrophy: Histopathological Studies of the Carrier State. Brain, 89, 109-120.
http://dx.doi.org/10.1001/archneur.1974.00490310098016
[34] Roy, S. and Dubowitz, V. (1970) Carrier Detection in Duchenne Muscular Dystrophy: A Comparative Study of Electron Microscopy, Light Microscopy and Serum Enzymes. Journal of the Neurological Sciences, 11, 65-79.
http://dx.doi.org/10.1016/0022-510X(70)90041-9
[35] Ionasescu, V., Zellweger, H. and Conway, T.W. (1971) Ribosomal Protein Synthesis in Ducheme Muscular Dystrophy. Archives of Biochemistry and Biophysics, 144, 51-58.
http://dx.doi.org/10.1016/0003-9861(71)90453-X
[36] Ionasescu, V., Zellweger, H., Shirk, P. and Conway, T.W. (1973) Identification of Carriers of Duchenne Muscular Dystrophy by Muscle Protein Synthesis. Neurology, 23, 497-501.
http://dx.doi.org/10.1212/WNL.23.5.497
[37] Roses, A.D., Roses, M.J., Miller, S.E., Hull, K.L. and Appel, S.H. (1976) Carrier Detection in Duchenne Muscular Dystrophy. New England Journal of Medicine, 294, 193-198.
http://dx.doi.org/10.1056/NEJM197601222940404
[38] Hobbins, J.C. and Mahoney, M.J. (1974) In Utero Diagnosis of Hemoglobinopathies—Technique for Obtaining Fetal Blood. New England Journal of Medicine, 290, 1065-1067.
http://dx.doi.org/10.1056/NEJM197405092901908
[39] Bodensteiner, J.B. and Engel, A.G. (1978) Intracellular Calcium Accumulation in Duchenne Dystrophy and Other Myopathies. A Study of 56, 7,000 Muscle Fibers in 114 Biopsies. Neurology, 28, 439-446.
http://dx.doi.org/10.1212/WNL.28.5.439
[40] Bertorini, T.E., Bhattacharya, S.K., Palmieri, G.M.A., Chesney, C.M., Pifer, D. and Baker, B. (1982) Muscle Calcium and Magnesium Content in Duchenne Muscular Dystrophy. Neurology, 32, 1088-1092.
http://dx.doi.org/10.1212/WNL.32.10.1088
[41] Schotland, D.L., Bonilla, E. and Wakayama, Y. (1980) Application of the Freeze Fracture Technique to the Study of Human Neuromuscular Diseases. Muscle & Nerve, 3, 21-27.
http://dx.doi.org/10.1002/mus.880030104
[42] Schotland, D.L., Bonilla, E. and Van Meter, M. (1977) Duchenne Dystrophy: Alteration in Plasma Membrane Structure. Science, 196, 1005-1007.
http://dx.doi.org/10.1126/science.860127
[43] Peluchretti, D., Mora, M., Protti, A. and Cornelio, F. (1985) Freeze-Fracture Analysis of the Muscle Fiber Plasma Membrane in Duchenne Dystrophy. Neurology, 35, 928-930.
http://dx.doi.org/10.1212/WNL.35.6.928
[44] Heimann-Patterson, T.D., Bonilla, E. and Schotland, D.L. (1982) Cancanavalin A Binding of the Cell Surfac of Duchenne Muscle in Vitro. Annals of Neurology, 12, 305-307.
http://dx.doi.org/10.1002/ana.410120317
[45] Brooke, M.H. (1986) Muscular Dystrophies. In: McSherry, N.C. and Victoria, M.V., Eds., A Clinician’s View of Neuromuscular Disease, Williams & Wilkins, Baltimore, London, Los Angles, Sytdney, 117-154.
[46] Ionasescu, R., Kaeding, L., Feld, R., Write, D., Cancilla, P., Kaeding, L. and Stern, L.Z. (1991) Alterations in Creatine Kinase in Fresh Muscle and Cell Cultures in Duchenne Dystrophy. Annals of Neurology, 9, 394-399.
http://dx.doi.org/10.1002/ana.410090413
[47] Thompson, E.J., Yasin, R., Van Beers, G., Nurse, K. and Al-Ani, S. (1977) Myogenic Defect in Human Muscular Dystrophy. Nature, 268, 241-243.
http://dx.doi.org/10.1038/268241a0
[48] Rothman, S.M. and Bischoff, R. (1983) Electrophysiology of Duchenne Dystrophy Myotubes in Tissue Culture. Annals of Neurology, 13, 176-179.
http://dx.doi.org/10.1002/ana.410130212
[49] Mawatari, S., Miranda, A. and Rowland, L.P. (1976) Adenyl Cyelase Abnormality in Duchenne Muscular Dystrophy: Muscle Cells in Culture. Neurology, 26, 1021-1026.
http://dx.doi.org/10.1212/WNL.26.11.1021
[50] Cerri, C.A., Willner, J.H. and Miranda, A.F. (1982) Adenylate Cyclase in Duchenne Fibroblasts. Journal of the Neurological Sciences, 53, 181-185.
http://dx.doi.org/10.1016/0022-510X(82)90004-1
[51] Rowland, L.P. (1980) Biochemistry of Muscle Membranes in Duchenne Dystrophy. Muscle & Nerve, 3, 3-20.
http://dx.doi.org/10.1002/mus.880030103
[52] Falk, R.S., Campion, D., Guthrie, B., Sparkes, R.S. and Fox, C.F. (1979) Phospharylation of the Red-Cell Membrane Proteins in Duchenne Muscular Dystrophy. New England Journal of Medicine, 300, 258-259.
http://dx.doi.org/10.1056/NEJM197902013000514
[53] Fischer, S., Tortolero, M., Piau, J.P., Delaunay, J. and Schapira, G. (1978) Protein Kinase and Adanylate Kinase of Erythrocyte Membrane from Patients with Duchenne Dystrophy. Clinica Chimica Acta, 88, 437-440.
http://dx.doi.org/10.1016/0009-8981(78)90278-4
[54] Roses, A.D., Mabry, M.E., Herbstreith, M.H., Shile, E.V. and Balakrishnan, O.V. (1982) Increased [32P]-Phospharylation of Spectrin Peptides in Duchenne Muscular Dystrophy. In: Schotland, D.L., Ed., Disorders of the Motor Unit, John Wiley & Sons, New York, 413-420.
[55] Mabry, M.E. and Roses, A.D. (1981) Increased 32P-Phoshorylase of Triptic Peptides of Erythrocytes Spectrin in Duchenne Muscular Dystrophy. Muscle & Nerve, 4, 489-493.
http://dx.doi.org/10.1002/mus.880040605
[56] Roses, A.D., Shile, P.E., Herbstreith, M.H. and Balakrishnan, C.V. (1981) Identification of Abnormality [32P]-Phoshorylated Cyanogen Bromide Cleavage Product of Erythrocyte Membrane Spectrin in Duchenne Muscular Dystrophy. Neurology, 31, 1026-1030.
http://dx.doi.org/10.1212/WNL.31.8.1026
[57] Arthur, H., de Niese, M., Jeffrey, P.L. and Austin, L. (1983) Plasma Lipoprotein in Duchenne Muscular Dystrophy. Biochemistry International, 6, 307-313.
[58] Ehrlich, P. (1885) Das sauerstufbudurfnis des organismus, in Eine Farbenanalytische Studies. Hirschwald, Berlin, pp. 167.
[59] Murphy, J.B. and Sturm, E. (1923) Conditions Determining the Transplantability of Tissues in the Brain. The Journal of Experimental Medicine, 39, 183-197.
http://dx.doi.org/10.1084/jem.38.2.183
[60] Sabin, F.R. (1916) The Origin and Development of the Lymphatic System. Johns Hopkins Hospital Reports, Johns Hopkins Press, Baltimore, 347-440.
[61] Ediden, M. (1972) Transplantation Antigens. Academic Press, New York, 125-140.
[62] Blalock, J.E. (1984) The Immune System as a Sensory Organ. The Journal of Immunology, 132, 1067-1070.
[63] Reichlin, S. (1993) Neuroendocrine-Immune Interactions. New England Journal of Medicine, 329, 1246-1253.
http://dx.doi.org/10.1056/NEJM199310213291708
[64] Sternberg, E.M., Chrousos, G.P., Wilder, R.L. and Gold, P.W. (1992) The Stress Response and the Regulation of Inflammatory Disease. Annals of Internal Medicine, 117, 854-866.
http://dx.doi.org/10.7326/0003-4819-117-10-854
[65] Weigent, D.A. and Blalock, J.E. (1987) Interactions between the Neuroendocrine and Immune Systems: Common Hormones Receptors. Immunological Reviews, 100, 79-108.
http://dx.doi.org/10.1111/j.1600-065X.1987.tb00528.x
[66] Tourtellotte, W. (1970) On Cerebrospinal Fluid Immunoglobulin-G (IgG) quotIents in Multiple Sclerosis and Other Disease. A Review and a New Formula to Estimate the Amount of IgG Synthesized Per Day by the Central Nervous System. Journal of the Neurological Sciences, 10, 279-304.
http://dx.doi.org/10.1016/0022-510X(70)90156-5
[67] Oldstone, M.B. and Dixon, F.J. (1968) Immunohistochemical Study of Allergic Encephalomyelitis. American Journal of Pathology, 52, 251-263.
[68] Miller, S.D., Vanderlugt, C.L., Begolka, W.S., Pao, W., Yauch, R.L., Neville, K.L., Katz-Levy, Y., Carrizosa, A. and Kim, B.S. (1997) Presistent Infection with Theiler’s Virus Leads to CNS Autoimmunity via Epitope Spreading. Nature Medicine, 3, 1133-1136.
http://dx.doi.org/10.1038/nm1097-1133
[69] Agnello, V. (1978) Complement Deficiency States. Medicne, 57, 1-23.
[70] Fearon, D.T. (1987) Structure and Functions of Compliment. In: Ataasi, M.Z., Vanoss, C.J. and Absolon, D.R., Eds., Molecular Immunology, Marcel Dekker Inc., New York, pp. 511.
[71] Volanakis, J.E. (1975) The Human Complement System. Journal of Oral Pathology & Medicine, 4, 195-221.
http://dx.doi.org/10.1111/j.1600-0714.1975.tb01742.x
[72] Stein, J.H. (1987) Complement Measurement. In: Puddy, S., Ed., Internal Medicine, 2nd Edition, Little Brown and Company Boston, Toronto, pp. 1184.
[73] Fishman, R.A. (1980) Cerebrospinal Fluid in Disorders of the Nervous System. Armarou, A., Hrtncry, M. and Shapiro, K., Eds., Sounders, Philadelphia, London, Toronto, 95-107.
[74] Milica, T.C., Brinar, V., Pauro, M., Vogrinc, Z. and Stambuk, N. (1998) Cerebrospinal Fluid Complement Activation in Neurological Diseases. Journal of the Neurological Sciences, 154, 173-181.
http://dx.doi.org/10.1016/S0022-510X(97)00225-6
[75] Isenberg, D.A. (1982) Immunoglobulin Deposition in Skeletal Muscle in Primary Muscle Disease. QJM: An International Journal of Medicine, 52, 297-310.
[76] Spulre, S. and Engel, A.G (1988) Unexpected Sarcolemental Complement on Membrane Attack Complex Deposits on Nonnecrotic Muscle Fibers in Muscular Dystrophies. Neurology, 50, 41-46.
http://dx.doi.org/10.1212/WNL.50.1.41
[77] Engel, A.G. and Biesecker, G. (1982) Complement Activation in Muscle Fiber Necrosis Demonstration of the Membrane Attack Complex of Complement in Necrotic Fibers. Annals of Neurology, 12, 289-296.
[78] Niebrój-Dobosz, I., Lukasiuk, M. and Niebrój-Dobosz, I. (1995) Immunoblot Analysis of Sarcoplasmic Calcium Binding Proteins in Duchenne Muscular Dystrophy. Journal of Neurology, 242, 82-86.
http://dx.doi.org/10.1007/BF00887821
[79] Minetti, C., Tanjii, K. and Bonilla, E. (1992) Immunologic Study of Vinculin in Duchenne Muscular Dystrophy. Neurology, 42, 1751-1754.
http://dx.doi.org/10.1212/WNL.42.9.1751
[80] Wochner, R.D., Drews, G., Strober, W. and Warren, S. (1966) Accelerated Breakdown of Immunoglobulin G (IgG) in Myotonic Dystrophy: A Hereditary Error of Immunoglobulin Catabolism. Journal of Clinical Investigation, 45, 321-329.
http://dx.doi.org/10.1172/JCI105346
[81] Larsen, B., Johnson, G., Loghem, E., Van Marshall, W.H., Newton, R.M., Pryse-Phillips, W. and Skanes, V. (1980) Immunoglobulin Concentration and Gm Allotypes in a Family with Thirty-Three Cases of Myotonic Dystrophy. Clinical Genetics, 18, 13-19.
http://dx.doi.org/10.1111/j.1399-0004.1980.tb01358.x
[82] Sanders, B.G., Kline, K. and Morton, C.J. (1980) Serum IgG Levels in the Storrs Strain of Hereditary Muscular Dystrophhic Chickens. Biochemical Genetics, 18, 1149-1158.
[83] Mancini, G., Carbonara, A.O. and Heremans, J.F. (1965) Immunochemical Quantitation of Antigens by Single Radial Immunodiffusion. Immunochemistry, 2, 235-254.
http://dx.doi.org/10.1016/0019-2791(65)90004-2
[84] Al-Hakeim, H.K. (2008) Serum Cortisol, Immunoglobulins and Some Complements among Depressed Patients. Indian Journal of Clinical Biochemistry, 23, 76-80.
http://dx.doi.org/10.1007/s12291-008-0018-2
[85] Olsson, R., Hellner, L., Lindstedt, G., Lundberg, P.A. and Teger-Nilsson, A.C. (1983) Plasma Proteins in Patients on Long Term Anti Epileptic Treatment. Clinical Chemistry, 29, 728-730.
[86] Riddoch, D. and Thompson, R.A. (1970) Immunoglobulin Levels in the Cerebrospinal Fluid. British Medicine Journal, 1, 396-399.
http://dx.doi.org/10.1136/bmj.1.5693.396
[87] Gholamoli, Y.P., Izadi, S. and Ghaderi, A. (2004) Immunological Correlates of Adults Onset Idiopathic Generalised Tonic-Clanic Epilepsy before and after Sodium Valporate Treatment, Iranion. The Journal of Immunology, 1, 105-110.
[88] Slavin, B.N., Fenton, G.M., Laundry, M. and Reynolds, E.H. (1974) Serum Immunoglobulin in Epilepsy. Journal of the Neurological Sciences, 23, 353-357.
http://dx.doi.org/10.1016/0022-510X(74)90153-1
[89] Moustafa, S., Osama, A., Saad, A., Elseed, S. and Moustafa, N. (2006) Immunotoxicity of Chronic Phenytoin Administration in Epileptic Patients. Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 43, 435-441.
[90] Kumar, S. (1989) Medico-Physical Studies on Epilepsy and Other Neurological Disorders. Ph. D. Thesis, University of Delhi, New Delhi.
[91] Anderson, P. and Moseklide, L. (1977) Immunoglobulin Levels and Autoantibodies in Epileptics on Long-Term Anti-convulsant Therapy. Acta Medica Scandinavica, 201, 69-74.
[92] Moore, T.L., Ryan Jr., R.E., Pohl, D.A., Roodman, S.T. and Ryan Sr., R.E. (1980) Immunoglobulin, Complement, and Immune Complex Levels during a Migrane Attack. Headache: The Journal of Headache and Face pain, 20, 9-12.
[93] Lord, G.D.A. and Duchworth, J.W. (1977) Immunoglobulin and Complement Studies in Migrance. Headache: The Journal of Head and Face Pain, 17, 163-168.
http://dx.doi.org/10.1111/j.1526-4610.1977.hed1704163.x
[94] Kumar, S., Kumar, V., Jain, D.C. and Mittal, R. (2013) Immunological Variations in Epileptic Children. Open Journal of Applied Sciences, 3, 71-91.